On Tuesday, Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) opened higher 41.40% from the last session, before settling in for the closing price of $8.14. Price fluctuations for QNRX have ranged from $5.01 to $48.30 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -144.01%. Company’s average yearly earnings per share was noted 71.66% at the time writing.
Quoin Pharmaceuticals Ltd ADR (QNRX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The most recent insider transaction that took place on Oct 14 ’25, was worth 128,640. In this transaction Director of this company bought 15,152 shares at a rate of $8.49, taking the stock ownership to the 15,153 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Operating Officer bought 555,556 for $0.45, making the entire transaction worth $250,000. This insider now owns 602,648 shares in total.
Quoin Pharmaceuticals Ltd ADR (QNRX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -9.73 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -15.05) by 5.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.96 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 71.66% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 47.33% during the next five years compared to -144.01% drop over the previous five years of trading.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Trading Performance Indicators
Check out the current performance indicators for Quoin Pharmaceuticals Ltd ADR (QNRX). In the past quarter, the stock posted a quick ratio of 1.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -698.99, a number that is poised to hit -4.41 in the next quarter and is forecasted to reach -15.43 in one year’s time.
Technical Analysis of Quoin Pharmaceuticals Ltd ADR (QNRX)
Compared to the last year’s volume of 0.31 million, its volume of 3.69 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 25.70%.
During the past 100 days, Quoin Pharmaceuticals Ltd ADR’s (QNRX) raw stochastic average was set at 13.89%, which indicates a significant decrease from 56.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.47 in the past 14 days, which was higher than the 1.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.93, while its 200-day Moving Average is $8.96. Nevertheless, the first resistance level for the watch stands at $14.09 in the near term. At $16.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $19.32. If the price goes on to break the first support level at $8.86, it is likely to go to the next support level at $6.22. Should the price break the second support level, the third support level stands at $3.63.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Key Stats
There are currently 588K shares outstanding in the company with a market cap of 6.79 million. Presently, the company’s annual sales total 0 K according to its annual income of -8,960 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -3,950 K.
